Testimonials and Navigation in Rheumatology
- Conditions
- Autoimmune DiseasesRheumatologic Disease
- Interventions
- Behavioral: Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiencesBehavioral: Video on the importance of good oral health for patients with AIRDBehavioral: Brochure on the importance of good oral health in AIRD patientsBehavioral: Brochure on COVID-19 vaccination in AIRD patientsBehavioral: Patient Navigation
- Registration Number
- NCT06469788
- Lead Sponsor
- University of Alabama at Birmingham
- Brief Summary
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
- Detailed Description
Black and Latinx persons are at higher risk for certain autoimmune and inflammatory rheumatic diseases (AIRD) and have experienced worse COVID-19 outcomes compared to their white counterparts. Given the risks of severe COVID-19 outcomes such as hospitalization and death in people with AIRD, COVID-19 vaccine is recommended in this population. Historically, overall vaccine uptake among people with AIRDs has been low, and this vaccine reluctance has extended to COVID-19 vaccination. While additional COVID-19 vaccine doses have offered considerable added protection against severe outcomes, only 20% of all vaccinated persons in Alabama (AL) and 45% in Massachusetts have obtained an additional dose of COVID-19 vaccine as of October 2022. Racial and ethnic minority groups have faced disparities in obtaining subsequent COVID-19 vaccines, particularly in under-resourced communities, including those in Alabama and Massachusetts. Together, these obstacles exacerbate existing health inequities among people of color and perpetuate worse COVID-19 outcomes.
We will conduct a randomized controlled study to test an intervention that seeks to address gaps in COVID-19 vaccine information and access inequities common in Black and Latinx populations.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1170
- Adults (18+ years) with known AIRD
- Black race and/or Latinx ethnicity
- Individuals who have not obtained the updated COVID-19 vaccine series (self-report)
-Lack of access to phone
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Attention Control: "Oral Health" video and "Oral Health" brochure Brochure on the importance of good oral health in AIRD patients Participants will review video on the importance of oral health in patients with AIRD and receive brochure on the same topic. "Storytelling" video including patient narratives, brochure and patient navigation Patient Navigation Participants will review video with narratives on COVID-19 vaccination in patients with AIRD, receive brochure on the same topic; and interact with patient navigators. "Storytelling" video including patient narratives, brochure and patient navigation Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences Participants will review video with narratives on COVID-19 vaccination in patients with AIRD, receive brochure on the same topic; and interact with patient navigators. "Storytelling" video including patient narratives, brochure and patient navigation Brochure on COVID-19 vaccination in AIRD patients Participants will review video with narratives on COVID-19 vaccination in patients with AIRD, receive brochure on the same topic; and interact with patient navigators. Attention Control: "Oral Health" video and "Oral Health" brochure Video on the importance of good oral health for patients with AIRD Participants will review video on the importance of oral health in patients with AIRD and receive brochure on the same topic.
- Primary Outcome Measures
Name Time Method Receipt of updated COVID-19 vaccination. 3 months We will measure rates of receipt of updated COVID-19 vaccination.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
Brigham Women's Hospital
🇺🇸Boston, Massachusetts, United States
University of Massachusetts Chan Medical School
🇺🇸Worcester, Massachusetts, United States